These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 32891400)
1. Incidence and Impact of Thrombocytopenia in Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents. Park S; Ahn JM; Kim TO; Park H; Cho SC; Kang DY; Lee PH; Park DW; Park SJ; Am J Cardiol; 2020 Nov; 134():55-61. PubMed ID: 32891400 [TBL] [Abstract][Full Text] [Related]
2. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents. Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773 [TBL] [Abstract][Full Text] [Related]
3. Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. Généreux P; Giustino G; Witzenbichler B; Weisz G; Stuckey TD; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri E; Yadav M; Francese DP; Palmerini T; Kirtane AJ; Litherland C; Mehran R; Stone GW J Am Coll Cardiol; 2015 Sep; 66(9):1036-45. PubMed ID: 26314532 [TBL] [Abstract][Full Text] [Related]
4. Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus. Wang HY; Cai ZX; Yin D; Yang YJ; Song WH; Dou KF Am J Cardiol; 2021 Mar; 142():14-24. PubMed ID: 33285091 [TBL] [Abstract][Full Text] [Related]
5. Impact of Baseline Thrombocytopenia on Bleeding and Mortality After Percutaneous Coronary Intervention. Ito S; Watanabe H; Morimoto T; Yoshikawa Y; Shiomi H; Shizuta S; Ono K; Yamaji K; Soga Y; Hyodo M; Shirai S; Ando K; Horiuchi H; Kimura T Am J Cardiol; 2018 Jun; 121(11):1304-1314. PubMed ID: 29628128 [TBL] [Abstract][Full Text] [Related]
6. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery]. Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341 [No Abstract] [Full Text] [Related]
7. Impact of baseline thrombocytopenia on the long-term outcome of patients undergoing elective percutaneous coronary intervention: An analysis of 9,897 consecutive patients. Liu S; Song C; Zhao Y; Guan C; Zhu C; Feng L; Xu B; Dou K Catheter Cardiovasc Interv; 2019 Feb; 93(S1):764-771. PubMed ID: 30585392 [TBL] [Abstract][Full Text] [Related]
8. Prediction of 1-year clinical outcomes using the SYNTAX score in patients with prior heart failure undergoing percutaneous coronary intervention: sub-analysis of the SHINANO registry. Minamisawa M; Miura T; Motoki H; Kobayashi H; Kobayashi M; Nakajima H; Kimura H; Akanuma H; Mawatari E; Sato T; Hotta S; Kamiyoshi Y; Maruyama T; Watanabe N; Eisawa T; Aso S; Uchikawa S; Senda K; Morita T; Hashizume N; Abe N; Ebisawa S; Izawa A; Miyashita Y; Koyama J; Ikeda U; Heart Vessels; 2017 Apr; 32(4):399-407. PubMed ID: 27709325 [TBL] [Abstract][Full Text] [Related]
9. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study. Wang HY; Wang Y; Yin D; Gao RL; Yang YJ; Xu B; Dou KF J Interv Cardiol; 2020; 2020():2985435. PubMed ID: 32405273 [TBL] [Abstract][Full Text] [Related]
11. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen). Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860 [TBL] [Abstract][Full Text] [Related]
12. Visit-to-visit variability of systolic blood pressure predicts all-cause mortality in patients received percutaneous coronary intervention with drug-eluting stents. Seo SM; Chung WB; Choi IJ; Koh YS; Ihm SH; Kim PJ; Chung WS; Seung KB Heart Vessels; 2018 May; 33(5):489-497. PubMed ID: 29151154 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease - 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 - . Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T; Circ J; 2015; 79(6):1282-9. PubMed ID: 25818902 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Age (<75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study). Faggioni M; Redfors B; Crowley A; Claessen BE; Farhan S; Mastoris I; Witzenbichler B; Maehara A; Weisz G; Généreux P; Ben-Yehuda O; Mehran R; Kirtane AJ; Stone GW Am J Cardiol; 2020 Mar; 125(5):685-693. PubMed ID: 31926634 [TBL] [Abstract][Full Text] [Related]